HCG 10000 IU
€70.00
Peptide
Retatrutide
Triple receptor agonist · GLP-1, GIP and glucagon
from €210.00
In stock Ships within 24h on working days
- Batch documentation with every order
- Order by 14:00 CET, ships today
- Free EU delivery over €150.00
Specification
| Classification | Investigational peptide |
|---|---|
| Receptor activity | GLP-1, GIP and glucagon |
| Presentation | Lyophilised powder |
| Storage | Store at −20 °C, protect from light |
| SKU | LN-RETA |
All products are supplied for research, analytical and educational purposes only. They are not intended for human consumption, medical use, diagnosis, treatment or prevention of any condition. By ordering you confirm you are of legal age and that the purchase, possession and use of these products comply with the regulations that apply where you are.
About Retatrutide
Retatrutide is an investigational peptide that activates three metabolic hormone receptors: GLP-1, GIP and glucagon. This triple-receptor activity has made it a significant subject of research into body weight, appetite regulation, glucose metabolism and energy expenditure.
Retatrutide remains investigational. It is not an approved medication for weight management or diabetes treatment.
How it works
Retatrutide activates GLP-1, GIP and glucagon receptors at the same time. These pathways influence several aspects of metabolism and energy balance.
- GLP-1 and GIP signalling can affect appetite, satiety, insulin secretion and glucose regulation
- Glucagon signalling can influence hepatic metabolism and energy expenditure
- The combined activity is under investigation for its potential to produce significant changes in body weight and metabolic health
Handling
Supplied lyophilised. Store the sealed vial at −20 °C away from light. Reconstitute with bacteriostatic water, added slowly down the vial wall, and do not shake.
For research, analytical and educational use only. Not for human consumption.